Zantac Users Need Medical Monitoring for Liver Cancer

Zantac is a medication used to relieve various stomach problems. However, Zantac can also cause liver cancer if taken for an extended period. Liver cancer is the most common type of cancer in the United States, and it affects about one in every 75 people. 

The article discusses how the drug Zantac may contribute to liver cancer. 

The Importance of a Personal Injury Lawyer for Representation 

When you face a personal injury, it is important to have a lawyer who understands the ins and outs of Zantac cancer lawsuits. An attorney with experience in this area can help you receive the compensation you deserve for your injuries. Experienced lawyers know how to deal with insurance companies and work hard to get you the best possible outcome for your case. They are also familiar with the various laws surrounding personal injury cases in your state. If you are dealing with a serious injury, it is crucial to have a skilled lawyer on your side. 

Monitor Zantac Users For Liver Cancer 

According to a study published in JAMA Internal Medicine, Zantac users should be monitored for liver cancer and other health problems. The study found that people who took Zantac or its generic equivalent, Ranitidine, were more likely to develop liver cancer than those who didn’t take the drug. They were also more likely to develop other health problems, including pancreatic cancer and heart problems.

The study looked at data from more than 300,000 people in the United States and Canada who took either Zantac or Ranitidine. It found that those who took the drug were about twice as likely to develop liver cancer as those who didn’t take it. They were also about three times as likely to develop pancreatic cancer and four times as likely to develop heart problems.

The chemical in Zantac that is believed to contribute to liver cancer is classified as a B2 carcinogen. A confirmed human carcinogen that has been linked with an increased risk of cancer. Despite this classification, Zantac is still available over the counter in many countries. 

How does NDMA contribute to liver cancer?

According to the International Agency for Research on Cancer, NDMA is a class 2A carcinogen, or “possibly carcinogenic to humans.” It indicates that there is no direct evidence that the substance causes cancer in people, but it is highly likely due to its ability to cause cancer in animals.

One way that NDMA may contribute to liver cancer is by disrupting enzymes in the liver. These enzymes are responsible for breaking down food and removing toxins from the body. When they are disrupted, it can damage DNA and increase cancer risk. NDMA may increase the risk of liver cancer by causing inflammation in the liver. It leads to the development of tumors in the organ.

Researchers found that the drug may disrupt enzymes in the liver and damage the DNA. It could result in liver cancer. While more research is needed, these findings suggest that people who take Zantac may be at a higher risk of developing liver cancer.

Treatment for Liver Cancer 

Liver cancer is a serious disease, and when diagnosed early, the tumors are usually much smaller, making treatment easier and often more successful. In a study of over 1,000 patients with liver cancer, those whose cancer was diagnosed early – before it had spread beyond the liver – were more likely to be alive five years later than those whose cancer was diagnosed at a later stage.

One reason for this is that early diagnosis allows for less invasive treatment options. For example, surgery can often be performed laparoscopically—through tiny incisions—rather than requiring a large open incision. And if the tumor is small enough, it may be possible to remove it completely without having to remove the entire liver.

Symptoms of Liver Cancer 

Liver cancer is a serious disease that can be difficult to diagnose. Early symptoms, such as jaundice, an enlarged liver or spleen, and abdominal pain and swelling, are often vague and can easily be mistaken for other conditions. 

As cancer progresses, patients may experience back pain and a loss of appetite. Unfortunately, cancer may have spread to other body parts when these specific symptoms develop. If you are experiencing any of these symptoms, it is important to see a doctor for diagnosis and treatment. 

Conclusion

Experts advise that users of Zantac should have their liver checked. If you are taking this medication and are experiencing any of the above symptoms, please contact your doctor right away. Do not stop taking your medication without consulting your physician first. Be aware of the risks and benefits of the medication.

What’s this?
This content is made possible by our partner. It is not written by and does not necessarily reflect the attitude, views, or opinions of the Westchester Magazine/ Hudson Valley Magazine editorial staff.